Suppr超能文献

目标、预算、阈值与机会成本——一种卫生经济学方法:一份药物经济学与结果研究协会(ISPOR)特别工作组报告[4]

Objectives, Budgets, Thresholds, and Opportunity Costs-A Health Economics Approach: An ISPOR Special Task Force Report [4].

作者信息

Danzon Patricia M, Drummond Michael F, Towse Adrian, Pauly Mark V

机构信息

Health Care Management, The Wharton School, University of Pennsylvania, Philadelphia, PA, USA.

Centre for Health Economics, University of York, York, UK.

出版信息

Value Health. 2018 Feb;21(2):140-145. doi: 10.1016/j.jval.2017.12.008.

Abstract

The fourth section of our Special Task Force report focuses on a health plan or payer's technology adoption or reimbursement decision, given the array of technologies, on the basis of their different values and costs. We discuss the role of budgets, thresholds, opportunity costs, and affordability in making decisions. First, we discuss the use of budgets and thresholds in private and public health plans, their interdependence, and connection to opportunity cost. Essentially, each payer should adopt a decision rule about what is good value for money given their budget; consistent use of a cost-per-quality-adjusted life-year threshold will ensure the maximum health gain for the budget. In the United States, different public and private insurance programs could use different thresholds, reflecting the differing generosity of their budgets and implying different levels of access to technologies. In addition, different insurance plans could consider different additional elements to the quality-adjusted life-year metric discussed elsewhere in our Special Task Force report. We then define affordability and discuss approaches to deal with it, including consideration of disinvestment and related adjustment costs, the impact of delaying new technologies, and comparative cost effectiveness of technologies. Over time, the availability of new technologies may increase the amount that populations want to spend on health care. We then discuss potential modifiers to thresholds, including uncertainty about the evidence used in the decision-making process. This article concludes by discussing the application of these concepts in the context of the pluralistic US health care system, as well as the "excess burden" of tax-financed public programs versus private programs.

摘要

我们特别工作组报告的第四部分聚焦于健康计划或支付方在面对一系列技术时,基于其不同价值和成本所做出的技术采用或报销决策。我们讨论了预算、阈值、机会成本和可承受性在决策过程中的作用。首先,我们探讨了预算和阈值在私人及公共健康计划中的使用情况、它们的相互依存关系以及与机会成本的联系。从本质上讲,每个支付方都应根据自身预算制定关于什么是物有所值的决策规则;持续使用每质量调整生命年成本阈值将确保在预算范围内实现最大的健康收益。在美国,不同的公共和私人保险计划可能会采用不同的阈值,这反映了它们预算慷慨程度的差异,也意味着获得技术的机会水平不同。此外,不同的保险计划可能会在我们特别工作组报告其他地方讨论的质量调整生命年指标基础上,考虑不同的额外因素。然后我们定义了可承受性,并讨论了应对它的方法,包括对撤资及相关调整成本的考量、延迟采用新技术的影响以及技术的比较成本效益。随着时间推移,新技术的出现可能会增加人们在医疗保健上的支出意愿。接着我们讨论了阈值的潜在修正因素,包括决策过程中所使用证据的不确定性。本文最后讨论了这些概念在美国多元化医疗保健系统背景下的应用,以及税收资助的公共项目与私人项目的“超额负担”。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验